Liver Cancer News and Research

RSS
Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
Researchers identify gene that could play role in energy requirements of liver cancer cells

Researchers identify gene that could play role in energy requirements of liver cancer cells

CHLA researchers succeed in better defining rare pediatric malignant liver disease

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Experimental drug protects mice from obesity-related liver disease

Experimental drug protects mice from obesity-related liver disease

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

Princeton scientists test cell-culture system to aid study of HBV infections

Princeton scientists test cell-culture system to aid study of HBV infections

Parents have substantial role in curbing drinking habits of adolescents

Parents have substantial role in curbing drinking habits of adolescents

IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery

IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

FDA approves fixed-dose combination tablet for treating adults with chronic hepatitis C

Computational analysis of open-access data points to new ways of using drugs

Computational analysis of open-access data points to new ways of using drugs

Scientists develop first app and method to predict heart events after liver transplant

Scientists develop first app and method to predict heart events after liver transplant

New study links hepatic inflammation to western diet

New study links hepatic inflammation to western diet

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

Contaminated blood scandal that infected thousands in 70’s and 80’s being investigated

New LI-RADS can improve interpretation of CT and MR imaging

New LI-RADS can improve interpretation of CT and MR imaging

Novel micro-cubes can efficiently deliver hydrophobic anti-tumor drug to cancer cells

Novel micro-cubes can efficiently deliver hydrophobic anti-tumor drug to cancer cells

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Simple treatment leads to sustained virological response in patients with thalassaemia and HCV

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

UNC researchers identify how class of antiviral drugs interacts with HCV

UNC researchers identify how class of antiviral drugs interacts with HCV